Literature DB >> 10752778

Pathological assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management.

M H El-Didi1, M M Moneer, H M Khaled, S Makarem.   

Abstract

The effectiveness of breast-conserving surgery for patients with locally advanced breast cancer (LABC) after neoadjuvant chemotherapy (NACT) is still a controversial issue, and variable incidences of locoregional failures have been reported. The present study was conducted to pathologically assess the response of LABC to NACT, and also to evaluate the efficacy of preoperative clinical examination and mammography in detecting these pathological changes. A total of 38 patients with LABC received NACT in the form of three cycles of fluorouracil/adriamycin/cyclophosphamide and were then subjected to a mastectomy. The residual tumors in the mastectomy specimens were measured, mapped, and compared to the pretreatment and preoperative clinical and mammographic findings for evaluation. An objective response to NACT was observed in 70.4% of the patients; however, only 26.7% of them were suitable candidates for conservative surgery. The rest of the responders showed an increased incidence of multifocality and in situ lesions localized within the original tumor-bearing area. Both clinical examinations and mammography were inadequate for the selection of candidates for breast conservation. Tumor regression by NACT is probably induced by a process of tumor segmentation. It is also associated with an increased incidence of multifocality and in situ lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752778     DOI: 10.1007/s005950050054

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

1.  Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.

Authors:  S E Singletary; M D McNeese; G N Hortobagyi
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860

Review 2.  Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.

Authors:  G Bonadonna
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

3.  MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation.

Authors:  S E Harms; D P Flamig; K L Hesley; M D Meiches; R A Jensen; W P Evans; D A Savino; R V Wells
Journal:  Radiology       Date:  1993-05       Impact factor: 11.105

Review 4.  The concept and implications of multicentricity in breast carcinoma.

Authors:  M D Lagios; P R Westdahl; M R Rose
Journal:  Pathol Annu       Date:  1981

5.  Multimodal therapy in locally advanced breast carcinoma.

Authors:  M J Lopez; D P Andriole; W G Kraybill; A Khojasteh
Journal:  Am J Surg       Date:  1990-12       Impact factor: 2.565

Review 6.  Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.

Authors:  G N Hortobagyi; F C Ames; A U Buzdar; S W Kau; M D McNeese; D Paulus; V Hug; F A Holmes; M M Romsdahl; G Fraschini
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

7.  Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging.

Authors:  D C Abraham; R C Jones; S E Jones; J H Cheek; G N Peters; S M Knox; M D Grant; D W Hampe; D A Savino; S E Harms
Journal:  Cancer       Date:  1996-07-01       Impact factor: 6.860

8.  Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast.

Authors:  G F Schwartz; R I Cantor; W A Biermann
Journal:  Arch Surg       Date:  1987-12

9.  Multidisciplinary treatment approach to locally advanced non-inflammatory breast cancer using chemotherapy and radiotherapy with or without surgery.

Authors:  E Touboul; J P Lefranc; J Blondon; M Ozsahin; S Mauban; L H Schwartz; M Schlienger; A Laugier; R A Guerin
Journal:  Radiother Oncol       Date:  1992-11       Impact factor: 6.280

10.  Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

Authors:  T J Powles; T F Hickish; A Makris; S E Ashley; M E O'Brien; V A Tidy; S Casey; A G Nash; N Sacks; D Cosgrove
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

View more
  12 in total

1.  Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

Authors:  Jason D Keune; Donna B Jeffe; Mario Schootman; Abigail Hoffman; William E Gillanders; Rebecca L Aft
Journal:  Am J Surg       Date:  2010-04       Impact factor: 2.565

2.  [Morphological response to therapy of breast carcinoma].

Authors:  F Länger; H-J Lück; H H Kreipe
Journal:  Pathologe       Date:  2004-11       Impact factor: 1.011

3.  Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins.

Authors:  Vivek Aggarwal; Gaurav Agarwal; Punita Lal; Narendra Krishnani; Anjali Mishra; Ashok K Verma; Saroj K Mishra
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

4.  The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery.

Authors:  Sadako Akashi-Tanaka; Takashi Fukutomi; Natsuko Sato; Eriko Iwamoto; Toru Watanabe; Noriyuki Katsumata; Masashi Ando; Kunihisa Miyakawa; Tadashi Hasegawa
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

5.  Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancer.

Authors:  Romeeta Trehan; Rajeev K Seam; Manoj K Gupta; Ashwani Sood; Kislay Dimri; Rohit Mahajan
Journal:  World J Nucl Med       Date:  2014-09

6.  Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer?

Authors:  Jordan J Atkins; Catherine M Appleton; Carla S Fisher; Feng Gao; Julie A Margenthaler
Journal:  J Oncol       Date:  2013-02-11       Impact factor: 4.375

7.  Biological markers and response to neoadjuvant taxane-based chemotherapy in patients with locally advanced breast cancer.

Authors:  Mohamed I El-Sayed; Doaa W Maximous; Madeha M Zakhary; Nabiel N H Mikhail
Journal:  ISRN Oncol       Date:  2012-12-17

8.  Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.

Authors:  Vinay Singhal; J P Singh; Ashima Lyall; Sunita Saxena; Anju Bansal
Journal:  BMC Cancer       Date:  2004-08-13       Impact factor: 4.430

9.  Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

Authors:  R M L Warren; L G Bobrow; H M Earl; P D Britton; D Gopalan; A D Purushotham; G C Wishart; J R Benson; W Hollingworth
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

10.  Detection of Post-Therapeutic Effects in Breast Carcinoma Using Hard X-Ray Index of Refraction Computed Tomography - A Feasibility Study.

Authors:  Susanne Grandl; Anikó Sztrókay-Gaul; Alberto Mittone; Sergey Gasilov; Emmanuel Brun; Alberto Bravin; Doris Mayr; Sigrid D Auweter; Karin Hellerhoff; Maximilian Reiser; Paola Coan
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.